Blog & Resources
Looking for my thoughts on everything from bioethics to movies? You came to the right place. And while you’re here, check out my free downloadable resources.
Sign up to be notified when new posts release.
In the Near Future: Uterus Transplants
The New York Times November 13 print edition ran an article by Denise Grady that announced "Uterus Transplants May Soon Help Some Infertile Women in the U.S. Become Pregnant." The Times considered the news so big that a press release came to my in-box. It's all going down at The Cleveland Clinic, where doctors expect to become the first in the US to transplant a uterus into a woman who lacks one—whether due to congenital factors, injury, or illness. The procedure would eliminate the need for a gestational surrogate.After giving birth to one or two children—by C-section—the woman receiving the transplanted uterus would have it removed so she can quit taking anti-rejection meds. An estimated 50,000 women in the United States might be candidates. Currently, eight have begun the screening process.The transplant team would remove the uterus, cervix, and part of the vagina from a recently deceased organ donor. (The uterus, if kept cold, can survive outside of the human body for six to eight hours.) The recipient's ovaries and fallopian tubes would be left in place, and after one year of healing, she would undergo an IVF/embryo transfer procedure.Sweden is the only place where doctors have already successfully completed uterine transplants. Nine recipients have delivered four babies. Another is due January 2016. Two failed and had to be removed—one, due to a blood clot; the other, due to infection. The Cleveland doctors plan to use deceased donors, so they won't put healthy women at risk. For a live donor, the operation takes seven to eleven hours and requires working near vital organs.Recipients must have ovaries. But because the fallopian tubes won't be connected to the transplanted uterus, a natural pregnancy will be impossible.
Bioethics in the News
STEM CELL PROCESS A FLASH IN THE PAN?
Bioethics in the News
(Reuters) A simple urine test for the virus that causes cervical cancer could offer a less invasive and more acceptable alternative to the conventional cervical smear test. (Read More)
(ABC News) The doctor who was the first American-treated Ebola patient testified before a congressional committee today recalling the horror and “humiliation” of a disease that has killed thousands. (Read More) [This is a chilling read.]
(New York Times) A Senate hearing on Tuesday set the stage for a coming debate over whether the federal government should continue financing a popular health insurance program for lower-income children now eligible for other coverage options. (Read More)
(Nature) Informed, reasoned and voluntary consent is core to the ethical conduct of research, but the norms vary across cultures. (Read More)
(UPI) Poisoning is the most common form of death by injury in the United States, and 90 percent of all poisoning deaths are caused by drug overdoses via both prescription and illicit drugs. (Read More)
(CNN) What we know and psychiatrists have diagnosed for decades as schizophrenia may really be eight separate diseases. (Read More)
(Medical Xpress) The greater morbidity and mortality associated with multiple births are reflected in the substantially higher inpatient hospital costs during the neonatal period and during the first year of life. (Read More)
(Newswise) “The emotive reaction to the Facebook experiment is proof of the public interest in this set of issues as well as an indication that best practices have yet to be identified.” (Read More)
Bioethics in the News
Thanks to the Center for Bioethics and Human Dignity for flagging these stories.
Lots of People on Antidepressants (Scientific American) The Mayo Clinic says about 13% of Americans, more than 1 in 10, take an antidepressant. Of women between the ages of 50 and 64, nearly 25% take an antidepressant. (Read More)
No Bucket Challenge for Ebola
A British Surrogate Mother Rejects Her Disabled Twin
Will Stem Cells Replace Heart Operations?
Scientists Have Coached Lab Cells to Make a Working Human Organ
Crime and IVF
No More Reading Glasses in the Future?
Do We Need a Different Approach to Cancer?
Lack of Toilets Puts Women's Health and Safety at Risk
Japanese Man Overdoes It with Surrogacy
Time and the Digital Now
I returned late Saturday night from an overnight trip to Nashville (though my bag took a detour on Delta and stayed gone the entire weekend). Why Nashville? My agent, Chip MacGregor, gathers all his authors annually and provides us with an industry update. He also offers info about how to market our books. We authors cover our travel and lodging expenses, and he covers the conference room and the content. Last year, Chicago; this year, Nashville. It’s always a great time to network with his other authors. And Chip could be a stand-up comic, so the time passes quickly.
Before the Saturday conference, I spent Friday night with a husband-wife team with whom I have long shared the infertility journey. They picked me up from my hotel, and for the first time I was able to meet their four-year-old twins conceived via IVF. Yay! What a joy to see their happy ending(s). The couple are also both my former writing students—one is a photographer, and both had terrific non-fiction book ideas. So the twins went to dinner with their grandmother, and the grown-ups cooked for me while we talked about life and art and writing and next steps for them. The time flew. And our fellowship reminded me why I do what I do.
Speaking of time (too little of it!), another highlight of my weekend was a delightful conversation with Abha Dawesar, whom I met for the first time. She did the TED Talk featured below, "Life in the Digital Now," which has garnered nearly a million hits.
According to the TED Talk description, Ms. Dawesar began her writing career as an attempt to understand herself—at age 7. (Just like me.) Understanding herself is a goal that remains at the center of her work. Sensorium, her most recent novel, explores the nature of time, self, and uncertainty, using Hindu mythology and modern science as prisms.
“At a very basic level, writing was always my way of apprehending the world,” she has said.She told me she moved from India to the United States to study at Harvard, and apparently Delhi appears at the center of her novels Family Values and Babyji. But the oversimplified genres of immigrant fiction or ethnic fiction do not appeal to her. “Those looking for a constant South Asian theme or Diaspora theme or immigrant theme will just be disappointed in the long run from my work,” she has said. “The only label I can put up with is that of a writer. And my ideas come from everywhere.”
In the days to come, you will probably hear from me about book marketing. But today I give you Abha Dawesar and something more foundational to living well. If you're anything like me, you will fall in love with her grandparents.
Bioethics in the News This Week
Iran’s Population Drive WorriesWomen’s Rights, Health Advocates (Reuters)Iran’s supreme leader has called for a population increase, in an edict likelyto restrict access to contraception that critics fear could damage women’srights and public health. In his 14-point decree, Ayatollah Ali Khamenei saidincreasing Iran’s 76 million-strong population would “strengthen nationalidentity” and counter “undesirable aspects of Western lifestyles.”
Bioethics: Making Headlines
Lots of interesting developments inthe field of bioethics this week. Take a look at these top stories, reported bythe Deerfield, Illinois, Center for Bioethics and Human Dignity:
Most detailed 3D map of human brain Adeceased 65-year-old woman has provided scientists with the material for thefirst super high-resolution, three-dimensional digital model of the humanbrain. (The Telegraph)
FDA approves morning after pill for women of childbearing age TheU.S. Food and Drug Administration approved Plan B emergencycontraceptive without a prescription for all women of childbearing age,officials say. (UPI)
In new tools to combat epidemics, the key is context Now a newproject called BioMosaic is building a more comprehensive picture offoreign-borne disease threats in the United States, by merging three separatedata tools into a single app for guiding decisions at the time of an outbreak.(New York Times)
HPV vaccine is credited in fall of teenagers’ infection rate Theprevalence of dangerous strains of the human papillomavirus (HPV) the mostcommon sexually transmitted infection in the US and a principal cause ofcervical cancer, has dropped by half among teenage girls in recent years, astriking measure of success for a vaccine against the virus that was introducedonly in seven years ago. (New York Times)
Egypt girl’s death puts spotlight on genitial mutilation The deathof a 13-year-old girl during a genital mutilation procedure has brought theissue back into the spotlight in Egypt. While some Egyptians fight for eradicationof the practice, others justify it in on religious grounds. (BBC)
New study tracks emotional health of “surrogate kids” Over thepast decade the number of births involving surrogacy with donor eggs and spermhas surged. What, experts wondered, does this mean for the mental and emotionalhealth of the growing number of kids who may or may not know the truth abouttheir distinctive origins? (Today)
Japan experts mull rules on chimeric embryos Japaneseexperts were on Tuesday set to discuss rules for experiments with animal-humanembryos, as scientists seek permission for tests that could see human organsproduced inside the growing body of an animal. (Fox News) Another news story suggested that human organs could be grown in animalswithin a year. (The Telegraph)
Abortion restrictions in states Forty-onestates have enacted abortion restrictions at different stages of pregnancy. (New York Times)
High court rules ‘pay-for-delay’ drug deals can face antitrustsuits A brand-name drug maker can be sued for violating antitrustlaws if it agrees to pay a potential competitor to delay selling a genericversion, the Supreme Court ruled. (Los Angeles Times)
Be prepared for the big genome leak Mostpeople in the US could soon know someone whose genome is held in a researchdatabase. Concerns are growing about our ability to control access to thatinformation. But many scientists feel that restricting access to genomic datafetters research. How long will it be until an idealistic and technicallyliterate researcher deliberately releases genome and trait information publiclyin the name of open science? (Nature)
Directed in vitro (IVF) technique may increase insulinresistance among offspring A special type of IVF may increase the riskfor insulin resistance among high-tech babies. (E! Science News)
IVF: First baby born using ’safer’ method In aworld first, a healthy baby has been born using a “safer” method of theinfertility treatment IVF, using a natural hormone to kick-start his mother’sovaries. (BBC)
Bioethics in the News
The Center for Bioethics and Human Dignity sends out a listing of top bioethics stories for the week. Some interesting stuff here:
Better prenatal testing does not mean more abortion
Between 70 and 85 percent of women in the U.S. confronted with a prenatal diagnosis of Down syndrome choose abortion but that number used to be higher. (The Atlantic)
Morning-after pills don’t cause abortion, studies say
The most heated part of the fight between the Obama administration and religious groups over new rules that require most health plans to cover contraception actually has nothing to do with birth control. It has to do with abortion. (NPR) [For all my past postings about this, search for Plan B in this blog in the right-column search engine.]
Stem cell-based bioartificial tissues and organs
Surgeon Paolo Macchiarini has made his name by successfully transplanting bioengineered stem cell-based trachea, composed of both artificial and biological material. He now plans to use the technique to recreate more complex tissues, such as the esophagus and diaphragm or organs such as the heart and lungs. (Science Daily)
Organ trafficking, a new crime of the 21st century
Organ transplant medicine is an incredible life-saving technology, under the right circumstances. Unfortunately, due to a shortage of available organs, a new crime of the 21st century, organ trafficking, is supplying organs to people with the money to pay big dollars for a new life. (The Epoch Times)
Why death is not the end of your social media life
Services such as LivesOn and DeadSocial plan to keep your friends and family updated on your Twitter and Facebook pages, even after you have passed away. (The Guardian )
A genetic code for genius?
In China, a research project aims to find the roots of intelligence in our DNA; searching for the supersmart. (Wall Street Journal )
Frozen embryo outcomes mixed
Frozen embryos yielded better birth outcomes on some measures compared with fresh embryos in vitro fertilization, but there were some concerning signals of big babies and excess early mortality, a Nordic population-based study indicated. (Med Page Today )
No increased cancer risk after IVF: Study
Women getting fertility treatments can be reassured that in vitro fertilization (IVF) does not increase their risk of breast and gynecological cancers, according to a new study of Israeli women. (NBC News )
In Vitro News
. A new study has shown that babies conceived by IVF using frozen embryos may be born later and weigh more than babies born from fresh embryos. This is good. And it's significant, because premature birth is linked with all sorts of issues. So if an embryo can survive the thaw, the odds of which are not in its favor, it seems to have an edge.
. Britain has seen a rise in the number of women choosing selective reduction in order to give birth to fewer children in a multiple pregnancy. One in three selective reductions involved pregnancies resulting from IVF. Of the 85 women opting for a selective reduction in 2010:
* 51 reduced twins to a single baby
* 20 reduced triplets to twins
* 9 expecting triplets chose to give birth to one child
* 5 women gave birth to twins following pregnancy with 4-5 fetuses
Officials are issuing a renewed call for restrictions on the number of embryos transferred to the uterus during IVF.
. A UK study suggests that the number of embryos to transfer—one or two—depends on the mother’s age. At all ages, patients should avoid the transfer of three or more in order to prevent adverse effects on both mother and child, according to this research. Two seems to be the optimum number for women over forty.
News from the World of Assisted Reproduction
Creepy: ethics and gene screening
Apparently IVF clinics now offer screening for breast cancer genes, so couples can opt to destroy any embryos that test positive.
IVF clinics are offering clients a service to allow them to "sift" embryos that carry breast cancer genes BRCA1 and BRCA2 using preimplantation genetic diagnosis (PGD).While most couples use PGD procedures to eliminate the risk of inherited sex-linked and single gene diseases (such as cystic fibrosis), PGD for BRCA genes cannot remove the risk completely—because there is 10% background risk of breast cancer.
Moreover, breast and ovarian cancers usually have a late onset. Prevention and therapeutic options are constantly improving, so the chances of successful treatment and many years of healthy life are high.
Nor is breast cancer inevitable. A defective BRCA gene increases susceptibility to breast or ovarian cancer, but does not make the diseases inevitable. However, with female carriers of a mutation in either gene having a lifetime risk of 60-80% for breast cancer, and a risk of 30-60% (BRCA1) or 5-20% (BRCA2) for ovarian cancer, most doctors favor the procedure.
In Australia, two leading IVF clinics in Melbourne told the Sydney Morning Herald that 10 couples had used the test to screen embryos since 2008. Using the test is said to double the cost of an IVF cycle from about $A3,500 to $7,000.
Bioethics in the News
Fertility Treatments and Birth Defects
Bioethics in the News
Ellen Painter Dollar on Reproductive Technologies
Infertility News This Week
Bioethics In the News
A new fertility-treatment study has found that women who receive three or more embryos have no better odds of giving birth than those who receive only two embryos. (Washington Post)
FDA Warning: About Illegal Stem Cell Treatments
The FDA announced this week that patients' hopes for cures leave them vulnerable prey for providers of illegal and potentially harmful stem cell treatments. (Medical Daily)
Surrogacy: A Growing International Injustice
International surrogacy is a growing business thanks to Westerners hiring poor women in developing countries to carry their babies. But media attention could change that. (Slate)
Skipping the Banks, Making Online Deals
Women are increasingly making online connections with men willing to donate sperm for free, skirting the expensive option of using a sperm bank with all its regulations, tests, and verifications. (ABC News)
Austria bans donor gametes in IVF
The European Court of Human Rights (ECHR) upheld Austria's ban on the use of donor sperm and eggs during in vitro fertilization procedures. You can read more here. Earlier the same court ruled against destroying human embryos for scientific research.
Making IVF Accessible
Experts are resisting cheap in vitro fertilization (IVF), a gentler technique priced at less than $300, as compared with the usual sixteen grand. The far less expensive version would, of course, cut into clinic profits.
Private treatment costs between $4,700 and $16,000 per cycle, and often patients need more than one cycle to conceive. But only one in five patients needing IVF in the West can do it. In the developing world—where infertility has more serious social consequences–that number is one in a hundred. Take sub-Saharan Africa, for example. A high birth rate conceals STDs, botched abortions, and pelvic infections. And the social consequences of infertility can mean divorce, polygamy, and even death. Yet at the moment IVF is only for the rich.
The alternative form uses generic drugs (clomiphene) and simple equipment, and the estimated cost includes personnel, not just meds and equipment. Because the alternative is less toxic and far less expensive, those seeking treatment could do IVF multiple times.
Clinics in Melbourne, Stockholm and Bologna have done pilot studies with 100 cycles each. They yielded a birth rate per cycle of about 12%. Standard IVF has rates two to three times that high. Yet a couple doing the less expensive form could multiply their number of tries, making rates comparable but still at a fraction of the cost. A 2007 study found that even natural-cycle IVF (without drugs) had a 43% cumulative pregnancy rate over a year—equivalent to standard IVF rates without the risks.
Standard IVF has a 50% drop-out rate and is physically and psychologically traumatic. The low-cost, low-impact approach is less traumatic and has a quicker recovery time. Thus patients would not have to wait three months or more before trying again.
A foundation is grafting low-cost facilities into existing clinics, and they are targeting India, Uganda, Indonesia, Ethiopia, and Tunisia. The European Society of Human Reproduction and Embryology aims to set up a similar program in Egypt, Paraguay, and in sub-Saharan Africa.
Source: www.bionews.org.uk/page_72984.asp
IVF Creator Wins the Nobel for Medicine
Dr. Robert G. Edwards, the British scientist who developed in vitro fertilization (IVF), won the 2010 Nobel Prize in Physiology or Medicine.
The prize committee in Sweden said Dr. Edwards "battled societal and establishment resistance to his development of the in vitro fertilization procedure, which has so far led to the birth of around 4 million people."
Those of us connected with the fertiliy industry for a few decades remember the creators as "Edwards and Steptoe." Dr. Steptoe did not share in the $1.5-million prize because Nobel rules require honorees to be alive at the time of the award, and he died 22 years ago.
Some news stories have mentioned that "the establishment" initially opposed IVF but--with the exception of the Roman Catholic Church--nobody has a problem with it today. And that's generally true. But it's not because hard-nosed critics somehow "evolved" into enlightened thinkers. At the time of Louise Brown's conception, no one knew what kind of risk scientists were taking with embroyos, nor did anyone know if IVF babies would be healthy. Caution was wisdom. And indeed earlier procedures were less efficient than today's practices. As the risks became known and/or decreased, some of us withdrew many of our objections. Yet doctors still discard embryos and/or take enormous risks with them. That's why we still try to train patients to be good managers of their own care. They can influence lab practices for handling their cases. Also, some scientists and ethicists are still concerned about a link between IVF and rare birth defects, but most feel the benefits outweigh the risks.